source
- Abivax reports ulcerative colitis trial cancer rates align with expectationsAbivax released new data from its Phase 3 trial of an ulcerative colitis candidate. The data show that the number of cancer cases observed was within the range normally expected for ulcerative col…
- Anthropic launches Claude Science, AI platform aimed at bioscience and drug discoveryAnthropic, known for its Claude Code AI coding assistant, announced a new product called Claude Science aimed at the life‑science sector. The platform is designed to help biopharma researchers wit…